PD Dr.med. Razvan T. Radulescu, M.D.
Molecular Concepts Research (MCR)
Muenster, Germany
 | ratura@gmx.net |
1978-85: Wilhelm-Hittorf-Gymnasium, Muenster (Abiturnote/final grade: 1.0)
1985-92: University of Muenster Medical School
1989: Harvard Medical School neurology rotation
http://razvantudor.net/RTR HMS neurology 1989.pdf
1991: Harvard Medical School endocrinology rotation
http://razvantudor.net/RTR MGH endocrinology 1991.pdf
1992: M.D. degree (University of Muenster); Title of doctoral thesis: "Biochemische und funktionelle Charakterisierung einer ยต-Opioid-Rezeptorbindungsstelle auf Zellen des Immunsystems"
since 1992: Founder & Coordinator, Molecular Concepts Research (MCR)
1998 evaluation of research work:
http://razvantudor.net/RTR work as seen by JF 1998.pdf
since 2002: Associate Professor of Pharmacology and Experimental Therapeutics (University of Munich/LMU); Title of thesis (Habilitation): "Von der Strukturanalyse des Retinoblastomproteins zu neuen, antiproliferativen Peptiden: Biolinguistische, biochemische und zellbiologische Untersuchungen"
2008 evaluation of research work:
http://razvantudor.net/RTR work as seen by VV 2008.pdf
2018: RB anti-cancer peptide (MCR peptide) work nominated for the Lasker Basic Medical Research Award
My research focus over the past two decades has been on structure-function relationships in insulin, IGFs, the retinoblastoma tumor suppressor protein (RB), IGFBP-3, IGFBP-5, insulin-degrading enzyme (IDE), the prion protein (PrP) and in various immunoglobulins as well as on anti-cancer peptides that I have derived from RB. This work has been the subject of many of my publications including in BBRC (1995, 2000 and 2010), the Journal of Endocrinology (1993, 1995 and 2000), Immunology Today (1998), TIBS (1994 and 2009), PNAS (2008), Protein & Peptide Letters (2014 and 2017) and the Encyclopedia of Signaling Molecules (2016).
1985-92: University of Muenster Medical School
1989: Harvard Medical School neurology rotation
http://razvantudor.net/RTR HMS neurology 1989.pdf
1991: Harvard Medical School endocrinology rotation
http://razvantudor.net/RTR MGH endocrinology 1991.pdf
1992: M.D. degree (University of Muenster); Title of doctoral thesis: "Biochemische und funktionelle Charakterisierung einer ยต-Opioid-Rezeptorbindungsstelle auf Zellen des Immunsystems"
since 1992: Founder & Coordinator, Molecular Concepts Research (MCR)
1998 evaluation of research work:
http://razvantudor.net/RTR work as seen by JF 1998.pdf
since 2002: Associate Professor of Pharmacology and Experimental Therapeutics (University of Munich/LMU); Title of thesis (Habilitation): "Von der Strukturanalyse des Retinoblastomproteins zu neuen, antiproliferativen Peptiden: Biolinguistische, biochemische und zellbiologische Untersuchungen"
2008 evaluation of research work:
http://razvantudor.net/RTR work as seen by VV 2008.pdf
2018: RB anti-cancer peptide (MCR peptide) work nominated for the Lasker Basic Medical Research Award
My research focus over the past two decades has been on structure-function relationships in insulin, IGFs, the retinoblastoma tumor suppressor protein (RB), IGFBP-3, IGFBP-5, insulin-degrading enzyme (IDE), the prion protein (PrP) and in various immunoglobulins as well as on anti-cancer peptides that I have derived from RB. This work has been the subject of many of my publications including in BBRC (1995, 2000 and 2010), the Journal of Endocrinology (1993, 1995 and 2000), Immunology Today (1998), TIBS (1994 and 2009), PNAS (2008), Protein & Peptide Letters (2014 and 2017) and the Encyclopedia of Signaling Molecules (2016).
